DG
AZN icon

DMC Group’s AstraZeneca AZN Stock Holding History

DMC Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,419
Closed -$221K – 130
2024
Q3 		$221K Sell
1,419
-522
-27% -$84.3K 0.18% 123
2024
Q2 		$303K Sell
1,941
-16
-0.8% -$2.41K 0.26% 98
2024
Q1 		$265K Sell
1,957
-12
-0.6% -$1.59K 0.23% 106
2023
Q4 		$265K Sell
1,969
-149
-7% -$19.4K 0.25% 106
2023
Q3 		$287K Sell
2,118
-54
-2% -$7.38K 0.27% 95
2023
Q2 		$311K Sell
2,172
-65
-3% -$9.56K 0.31% 92
2023
Q1 		$313K Buy
2,237
+15
+0.7% +$2.02K 0.32% 91
2022
Q4 		$308K Buy
2,222
+231
+12% +$29K 0.35% 85
2022
Q3 		$221K Buy
1,991
+59
+3% +$7.49K 0.27% 100
2022
Q2 		$255K Buy
+1,932
New +$253K 0.3% 88
2022
Q1 		– Sell
-2,090
Closed -$248K – 106
2021
Q4 		$248K Buy
+2,090
New +$246K 0.21% 114

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

DMC Group's AZN Position: Q4 2024 in Review

DMC Group sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 1,419 shares — an estimated $221K sold.

DMC Group first reported a position in AZN in Q4 2021 and held it in 11 quarters. The position peaked at $313K in Q1 2023. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • DMC Group reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • DMC Group sold 1,419 AstraZeneca shares in Q4 2024, an estimated $221K.
  • DMC Group first reported a position in AstraZeneca in Q4 2021 and held it in 11 quarters.
  • DMC Group's AstraZeneca position peaked at $313K in Q1 2023.
  • 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on DMC Group's 13F filing for Q4 2024, filed 23 Jan 2025.